Observational studyJournal of neurology2025

Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.

Alessandro Cagol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.